Neuroleptic Malignant Syndrome

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1986 English Publisher:Royal College of PsychiatristsJournal:British Journal of Psychiatry, volume 148, pages 47-51 (issn: 0007-1250, eissn: 1472-1465,

Copyright policy )

Authors: R J, Abbott; L A, Loizou;

doi: 10.1192/bjp.148.1.47

pmid: 3513883

Neuroleptic Malignant Syndrome

- Summary
- Subjects
- Metrics

Abstract

The neuroleptic malignant syndrome (NMS) occurs as a hypersensitivity response in certain patients exposed to neuroleptics. It is a relatively rare, but potentially lethal complication, the incidence of which may have been underestimated. Recent interest in NMS has arisen due to the recognition that specific therapy may now be available. This review summarises the clinical features and discusses recent ideas regarding aetiology and treatment.

Keywords

Adult, Dantrolene, Body Temperature, Muscle Rigidity, Rats, Diagnosis, Differential, Amantadine, Animals, Humans, Neuroleptic Malignant Syndrome, Female, Bromocriptine

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	74
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%